What Drug Interactions Does Omeprazole Have, and Which Are Most Serious?

Omeprazole has multiple contraindicated drug combinations documented in FDA drug labeling and NIH/NLM clinical data. The most serious of these involve antiplatelet medications (clopidogrel), certain HIV treatment regimens (rilpivirine-containing therapies and atazanavir), and clarithromycin, which is often paired with omeprazole in ulcer treatment but carries specific restrictions. These interactions are not theoretical: they are supported by clinical evidence showing loss of therapeutic effect, reduced drug effectiveness, or risk of serious harm. If you take omeprazole and are prescribed any new medication, you should always verify with your pharmacist that it is safe to combine.

What Is Omeprazole, and How Does It Work?

Omeprazole is a proton pump inhibitor (PPI), a class of medications that reduce stomach acid production. It works by blocking the enzyme responsible for releasing acid into the stomach, making it effective for treating acid reflux, ulcers, and related conditions. Omeprazole is available over the counter at lower doses and by prescription at higher doses, making it one of the most widely used medications in the United States.

Because omeprazole alters stomach acid levels and affects how the body processes certain medications, it can interfere with the absorption and metabolism of other drugs. Additionally, omeprazole inhibits the liver enzyme CYP2C19, which breaks down many other medications. These mechanisms mean that omeprazole can significantly change how certain drugs work in your body—sometimes making them less effective, sometimes increasing their levels to unsafe concentrations.

Most Serious Documented Interactions: What the Evidence Shows

Omeprazole and Clopidogrel Bisulfate (Plavix)

This is among the most clinically important omeprazole interactions. Omeprazole significantly reduces the antiplatelet activity of clopidogrel when taken together or even when the two drugs are separated by 12 hours.

Here is why this matters: Clopidogrel is an antiplatelet medication prescribed to prevent blood clots after a heart attack, stroke, or certain stent procedures. Clopidogrel is a "prodrug," meaning it must be converted by the liver into its active form to work. The enzyme CYP2C19 is responsible for this conversion. Omeprazole blocks CYP2C19, which means less of clopidogrel is converted to its active form. The result, according to the source record, is substantially reduced antiplatelet activity—meaning clopidogrel becomes less effective at preventing clots.

If you take clopidogrel for heart or stroke prevention and are also taking omeprazole, this combination is contraindicated, meaning it should be avoided. The FDA source record states: "Avoid concomitant use." This is not a minor interaction that requires only monitoring; it is a serious concern that warrants a change in your acid-reflux medication or an alternative antiplatelet strategy, decided by your physician.

Omeprazole and Atazanavir (HIV Medication)

Omeprazole reduces plasma levels of atazanavir (a protease inhibitor used to treat HIV) by approximately 94%, according to the documented interaction record. This dramatic reduction may result in loss of therapeutic effect and development of drug resistance—a serious outcome in HIV management.

The documented mechanism is that omeprazole increases gastric pH (reduces stomach acidity), which changes how well atazanavir is absorbed from the gastrointestinal tract. Atazanavir requires an acidic environment for proper absorption. When omeprazole neutralizes stomach acid, much less atazanavir enters the bloodstream.

Concomitant use of omeprazole and atazanavir is not recommended according to the source record. If you are taking atazanavir for HIV and need acid reflux treatment, your HIV specialist and gastroenterologist must choose an alternative PPI or acid-reducing agent that does not interfere with atazanavir absorption.

Omeprazole and Rilpivirine-Based HIV Regimens

Omeprazole is contraindicated with multiple rilpivirine-containing antiretroviral combinations, including:

• Emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
• Emtricitabine, rilpivirine, and tenofovir disoproxil fumarate
• Rilpivirine tablets (standalone)
• Dolutegravir sodium and rilpivirine hydrochloride (JULUCA)

In each case, the FDA source record states that coadministration is contraindicated due to potential for loss of virologic response and development of resistance. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) whose absorption is also pH-dependent; omeprazole's acid-reducing effect reduces rilpivirine levels substantially. Like atazanavir, this poses a serious risk of treatment failure and resistance development.

Clarithromycin Combination Therapy: A Complex Contraindication

The interaction between omeprazole and clarithromycin (often prescribed together as part of a triple or quadruple therapy for H. pylori ulcer infection) is noteworthy because the drugs are frequently used as a pair, yet serious risks exist.

The FDA drug label for clarithromycin states: "Concomitant administration of clarithromycin with other drugs can lead to serious adverse reactions, including potentially fatal arrhythmias, and are contraindicated." Similarly, the omeprazole label notes that clarithromycin coadministration requires careful attention to clarithromycin's contraindications, which include serious drug interactions.

The source records do not specify the exact mechanism of this interaction in the supplied data. However, clarithromycin is a potent inhibitor of CYP3A4 (a liver enzyme), which can raise the levels of many medications in the bloodstream. When clarithromycin is combined with omeprazole, complex metabolic effects can occur. If you are prescribed clarithromycin with omeprazole—even for common H. pylori treatment—your pharmacist and physician must verify that this combination is appropriate for your specific situation and other medications.

The FDA labeling references suggest that there are established protocols and precautions for this combination in certain contexts (such as H. pylori eradication), but the interaction itself is serious enough to warrant explicit documentation and ongoing monitoring.

Other Documented Contraindicated Combinations

Omeprazole and Amoxicillin

Amoxicillin, an antibiotic often paired with omeprazole and clarithromycin for H. pylori treatment, carries drug interactions that the FDA labels as contraindicated when used in certain combinations. The FDA drug label for omeprazole references amoxicillin's own interaction profile, noting that "amoxicillin also has drug interactions" and directing readers to amoxicillin's prescribing information.

This is a case where the contraindication is not absolute for every use of amoxicillin with omeprazole, but rather requires careful assessment depending on other medications and patient factors. If H. pylori treatment is being considered, this requires specialist oversight.

Omeprazole and Fosamprenavir Calcium (HIV Protease Inhibitor)

The FDA drug label for fosamprenavir calcium indicates that while fosamprenavir calcium (with or without ritonavir boosting) can be coadministered with omeprazole without change in amprenavir concentrations, the label groups PPIs including omeprazole among drugs that warrant careful review. The mechanism and clinical impact vary depending on whether ritonavir is part of the regimen, and the labeling indicates that the specific combination requires prescriber knowledge of the detailed interaction profile.

Understanding How Omeprazole Affects Other Medications: Background Pharmacology

To understand why omeprazole interacts with so many medications, it helps to know its two main effects on drug metabolism and absorption:

1. CYP2C19 Inhibition: Omeprazole blocks the liver enzyme CYP2C19, which metabolizes many drugs including clopidogrel. When this enzyme is inhibited, those drugs build up in the bloodstream or, in the case of clopidogrel, fail to be converted to their active form.
2. Increased Gastric pH (Reduced Stomach Acid): Omeprazole's primary action is to reduce stomach acid. Some medications—especially certain HIV protease inhibitors and rilpivirine—require acidic conditions for absorption. When omeprazole raises stomach pH, these drugs are poorly absorbed, leading to subtherapeutic blood levels.

These mechanisms are well established in pharmacology and explain why omeprazole has such a broad interaction profile, particularly with drugs that depend on CYP2C19 metabolism or acid-dependent absorption.

Hypothetical Example: How These Interactions Might Affect You

Hypothetical Scenario 1: Heart Patient on Clopidogrel

Suppose you had a heart attack and received a stent. Your cardiologist prescribes clopidogrel to prevent clot formation. You also have chronic acid reflux and have been taking omeprazole over the counter. You fill both prescriptions at the same pharmacy. According to the documented interaction record, omeprazole reduces clopidogrel's antiplatelet activity by up to 50% or more, potentially leaving you at risk for stent thrombosis (clot formation inside the stent). Your pharmacist should flag this combination and contact your cardiologist to discuss an alternative acid-reflux medication or a different antiplatelet strategy. This is not a situation in which you should proceed without explicit physician approval.

Hypothetical Scenario 2: HIV Patient on Rilpivirine

You are taking JULUCA (dolutegravir and rilpivirine) as part of your HIV treatment regimen. You develop heartburn and, without checking with your HIV specialist, start omeprazole. According to the FDA contraindication, omeprazole substantially reduces rilpivirine levels, potentially allowing HIV viral replication and resistance to develop. Your viral load could increase, and future treatment options could be limited by newly resistant virus. This scenario underscores why HIV patients must discuss any new medication—including over-the-counter acid reducers—with their HIV specialist before starting.

At-a-Glance: Omeprazole Contraindicated Drug Combinations

• Clopidogrel bisulfate (Plavix): Contraindicated. Omeprazole reduces antiplatelet activity via CYP2C19 inhibition.
• Atazanavir: Contraindicated. Omeprazole reduces atazanavir levels by ~94% due to pH-dependent absorption.
• Rilpivirine-containing regimens (rilpivirine tablets, emtricitabine/rilpivirine/tenofovir combinations, JULUCA): Contraindicated. Risk of loss of virologic response and resistance.
• Clarithromycin: Contraindicated or requires careful oversight per FDA labeling, with risk of serious arrhythmias and adverse reactions.
• Amoxicillin (in certain combination therapies): Requires careful review per FDA labeling.
• Fosamprenavir calcium: Requires careful assessment depending on boosting agent and other medications.

Questions to Ask Your Pharmacist or Physician

If you are taking omeprazole or considering starting it, ask your healthcare provider:

• "Do any of my current medications interact with omeprazole? Specifically, am I taking clopidogrel, any HIV medications, or clarithromycin?"
• "Is there an alternative acid-reflux medication that would work for me without interacting with my other drugs?"
• "How long do I need to take omeprazole? Are there reasons to use the lowest effective dose or to take breaks from it?"
• "If I need to start a new medication, how will you check it against my omeprazole?"
• "Are there any over-the-counter medications or supplements I should avoid while on omeprazole?"
• "If I'm taking omeprazole for over-the-counter heartburn relief, should I talk to my doctor about whether I really need it, or whether a different approach might work?"

Key Takeaways

• Omeprazole has multiple contraindicated drug combinations documented in FDA labeling, including clopidogrel, atazanavir, rilpivirine-based HIV regimens, and clarithromycin. "Contraindicated" means these combinations should not be used together.
• The most serious interactions involve loss of therapeutic effect (antiplatelet activity in clopidogrel, HIV suppression in rilpivirine and atazanavir regimens) or risk of life-threatening adverse events (clarithromycin-related arrhythmias).
• Omeprazole's interactions arise from two main mechanisms: inhibition of the liver enzyme CYP2C19 and reduction of stomach acid, both of which affect how other drugs are processed or absorbed.
• If you take omeprazole—especially over the counter—always inform your pharmacist and physician, particularly if you are on antiplatelet therapy, HIV medications, or other chronic medications.
• Never start, stop, or change omeprazole or any medication without discussing it with your pharmacist or physician, especially if you have cardiac conditions, HIV infection, or complex medication regimens.

Sources

• FDA Drug Database (Open.FDA.gov) — Direct access to FDA-approved drug labeling and contraindication records.
• DailyMed (NLM/NIH) — Full FDA-approved prescribing information for omeprazole, clopidogrel, atazanavir, rilpivirine, clarithromycin, and other medications discussed.
• RxNorm (NLM/NIH) — Standardized drug naming and interaction database used in this guide.
• PubMed Central (NIH/NLM) — Peer-reviewed clinical and pharmacological literature on omeprazole and drug interactions.

Take Control of Your Medications Today

Omeprazole is safe and effective when used appropriately and without contraindicated drug combinations. However, its widespread use—both by prescription and over the counter—means many people take it without fully understanding its interaction risks. You have the power to protect your health by reviewing your complete medication list with a pharmacist before starting omeprazole, and by reporting any new medications to your pharmacist or physician while you are on it.

Visit checkdruginteractions.com to enter all your medications and check for documented interactions in real time. The tool is free, evidence-based, and returns only FDA-documented and clinically significant interactions. Use it to build a comprehensive safety review before you fill your next prescription. Then confirm any questions or concerns with your pharmacist or physician—they know your complete medical history and can make the final decision about whether a combination is right for you.